- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↑ 0.73%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 40 SMA
- 500 SMA
Returns
CAGR returns till date
CAGR returns of Kotak Healthcare Fund - Regular Plan - Growth Option and its peers as on 3 November, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| Kotak Healthcare Fund - Regular Plan - Growth Option | 26.61% | 0.73% | 3.49% | 0.06% | 1.31% | 21.83% | - | - | - | - |
| SBI MNC FUND - REGULAR PLAN -GROWTH | 10.97% | 0.76% | 2.91% | -1.37% | -4.37% | 9.5% | 6.24% | 6.5% | 11.65% | 10.32% |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | 21.07% | 0.61% | 3.01% | 1.04% | -0.98% | 16.5% | 23.22% | 17.89% | 23.4% | 13.78% |
| SBI COMMA Fund - REGULAR PLAN - Growth | 0.8% | 0.52% | 2.72% | -0.7% | -4.78% | 1.88% | 14.13% | 9.06% | 16.65% | 13.73% |
| SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth | -5.29% | 1.31% | 3.83% | 3.85% | -5.01% | -4.45% | 8.98% | 6.45% | 11.2% | 11.03% |
| SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH | -1.4% | 0.59% | 3.73% | 2.11% | -5.38% | -2.2% | 11.18% | 14.06% | 17.54% | 14.3% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | - | - | - | - | 39.94% | -7.42% |
Discrete returns (monthly)
| Month | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 | Sep 2026 | Oct 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -4.69% | 7.38% | -4.27% | 7.61% | 5.37% | 7.62% | 3.76% | 3.49% | -0.61% | -0.67% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|
| Returns | 9.33% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 99.66% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.34% |
Equity
| Name | Symbol / ISIN | Sector | Weight % | Other links |
|---|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. | SUNPHARMA (INE044A01036) | Pharmaceuticals and Biotechnology | 13.96% | |
| Divis Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals and Biotechnology | 9.25% | |
| TORRENT PHARMACEUTICALS LTD. | TORNTPHARM (INE685A01028) | Pharmaceuticals and Biotechnology | 4.75% | |
| MOLBIO DIAGNOSTICS LIMITED | (INE869T01028) | Healthcare Services | 4.53% | |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 4.34% | |
| Ami Organics Ltd | ACUTAAS (INE00FF01025) | Pharmaceuticals and Biotechnology | 3.91% | |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals and Biotechnology | 3.67% | |
| PARK MEDI WORLD LIMITED (PARK HOSPITAL) | PARKHOSPS (INE119201023) | Healthcare Services | 3.36% | |
| YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTD | YATHARTH (INE0JO301016) | Healthcare Services | 3.25% | |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 3.25% | |
| Gland Pharma Limited | GLAND (INE068V01023) | Pharmaceuticals and Biotechnology | 3.04% | |
| SAI LIFE SCIENCES LIMITED | SAILIFE (INE570L01029) | Pharmaceuticals and Biotechnology | 3.04% | |
| Fortis Healthcare India Ltd | FORTIS (INE061F01013) | Healthcare Services | 2.95% | |
| MANKIND PHARMA LTD | MANKIND (INE634S01028) | Pharmaceuticals and Biotechnology | 2.84% | |
| Marksans Pharma Ltd | MARKSANS (INE750C01026) | Pharmaceuticals and Biotechnology | 2.51% | |
| Laurus Labs Ltd | LAURUSLABS (INE947Q01028) | Pharmaceuticals and Biotechnology | 2.49% | |
| KRISHNA INSTITUTE OF MEDICAL | KIMS (INE967H01025) | Healthcare Services | 2.46% | |
| RUBICON RESEARCH LIMITED | RUBICON (INE506V01022) | Pharmaceuticals and Biotechnology | 2.37% | |
| ANTHEM BIOSCIENCES LTD | ANTHEM (INE0CZ201020) | Pharmaceuticals and Biotechnology | 2.33% | |
| Ajanta Pharma Ltd. | AJANTPHARM (INE031B01049) | Pharmaceuticals and Biotechnology | 2.11% | |
| VIYASH SCIENTIFIC LTD | VIYASH (INE807F01027) | Pharmaceuticals and Biotechnology | 2.01% | |
| ORCHID PHARMA LIMITED | ORCHPHARMA (INE191A01027) | Pharmaceuticals and Biotechnology | 1.64% | |
| CORONA REMEDIES LIMITED | CORONA (INE02ZQ01018) | Pharmaceuticals and Biotechnology | 1.60% | |
| EMCURE PHARMACEUTICALS LIMITED | EMCURE (INE168P01015) | Pharmaceuticals and Biotechnology | 1.57% | |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals and Biotechnology | 1.57% | |
| JUBILANT INGREVIA LTD. | JUBLINGREA (INE0BY001018) | Chemicals and Petrochemicals | 1.49% | |
| RAINBOW CHILDRENS MEDICARE LTD | RAINBOW (INE961O01016) | Healthcare Services | 1.29% | |
| Pfizer Ltd. | PFIZER (INE182A01018) | Pharmaceuticals and Biotechnology | 1.16% | |
| JUBILANT PHARMOVA LIMITED | JUBLPHARMA (INE700A01033) | Pharmaceuticals and Biotechnology | 1.15% | |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals and Biotechnology | 1.14% | |
| METROPOLIS HEALTHCARE LTD. | METROPOLIS (INE112L01020) | Healthcare Services | 1.14% | |
| Zydus Lifesciences Ltd. | ZYDUSLIFE (INE010B01027) | Pharmaceuticals and Biotechnology | 1.13% | |
| DR.Lal Pathlabs Ltd | LALPATHLAB (INE600L01024) | Healthcare Services | 1.11% | |
| INNOVA CAPTABS LTD | INNOVACAP (INE0DUT01020) | Pharmaceuticals and Biotechnology | 1.08% | |
| LAXMI DENTAL LIMITED | LAXMIDENTL (INE0WO601020) | Healthcare Equipment and Supplies | 0.17% |
Portfolio data is as on date 31 August, 2026
NAV history
Kotak Healthcare Fund - Regular Plan - Growth Option - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 3 November, 2026 | 16.829 | 0.73% |
| 2 November, 2026 | 16.707 | 0.37% |
| 30 October, 2026 | 16.646 | 0.6% |
| 29 October, 2026 | 16.547 | 0.84% |
| 28 October, 2026 | 16.409 | 0.91% |
| 27 October, 2026 | 16.261 | 2.64% |
| 26 October, 2026 | 15.843 | 1.6% |
| 23 October, 2026 | 15.593 | -0.92% |
| 22 October, 2026 | 15.738 | -0.21% |
| 21 October, 2026 | 15.771 | -1.31% |
| 19 October, 2026 | 15.98 | -1.52% |
| 16 October, 2026 | 16.226 | 0.48% |
| 15 October, 2026 | 16.149 | -0.52% |
| 14 October, 2026 | 16.234 | -1.07% |
| 13 October, 2026 | 16.41 | -0.36% |
| 12 October, 2026 | 16.47 | -0.27% |
| 9 October, 2026 | 16.514 | 0.4% |
| 8 October, 2026 | 16.448 | -2.64% |
| 7 October, 2026 | 16.894 | 0.3% |
| 6 October, 2026 | 16.843 | 1.34% |
| 5 October, 2026 | 16.62 | -1.18% |
| 1 October, 2026 | 16.819 | 0.29% |
| 30 September, 2026 | 16.771 | -1.95% |
| 29 September, 2026 | 17.104 | 0.53% |
| 28 September, 2026 | 17.013 | -1.24% |
| 25 September, 2026 | 17.226 | -0.35% |
| 24 September, 2026 | 17.287 | -0.83% |
| 23 September, 2026 | 17.431 | 1.25% |
| 22 September, 2026 | 17.216 | -0.5% |
| 21 September, 2026 | 17.303 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Kotak Healthcare Fund - Regular Plan - Growth Option?
The latest NAV of Kotak Healthcare Fund - Regular Plan - Growth Option is 16.829 as on 3 November, 2026.What are YTD (year to date) returns of Kotak Healthcare Fund - Regular Plan - Growth Option?
The YTD (year to date) returns of Kotak Healthcare Fund - Regular Plan - Growth Option are 26.61% as on 3 November, 2026.What are 1 year returns of Kotak Healthcare Fund - Regular Plan - Growth Option?
The 1 year returns of Kotak Healthcare Fund - Regular Plan - Growth Option are 21.83% as on 3 November, 2026.What are top 10 holdings of Kotak Healthcare Fund - Regular Plan - Growth Option?
Top 10 holdings of Kotak Healthcare Fund - Regular Plan - Growth Option are:- SUN PHARMACEUTICAL INDUSTRIES LTD.
- Divis Laboratories Ltd.
- TORRENT PHARMACEUTICALS LTD.
- MOLBIO DIAGNOSTICS LIMITED
- Max Healthcare Institute Ltd.
- Ami Organics Ltd
- Cipla Ltd.
- PARK MEDI WORLD LIMITED (PARK HOSPITAL)
- YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTD
- Apollo Hospitals Enterprise Ltd.
- Gland Pharma Limited
What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for Kotak Healthcare Fund - Regular Plan - Growth Option?
Kotak Healthcare Fund - Regular Plan - Growth Option is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)Holding period Tax rate Less than 1 year (STCG) 20% More than 1 year (LTCG) Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.